Neulasta
· Patent Litigation & Settlement History ↓
Current GenericRadar decision
GNR judgment: DEEP_REVIEW. Reference year: 2014. Anchor type: EXCLUSIVITY. Patent anchor: not recorded. Exclusivity anchor: 2014-01-31. Anchor date: 2014-01-31. Patent tail: not established. Exclusivity tail: not established. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.
Patent estate
| Patent | Effective date | Official listing | TRUE_DS | DS grade | Claim classification / basis | PTE | PED | Family |
|---|---|---|---|---|---|---|---|---|
| 9856287 | 2030-06-21 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
Regulatory exclusivity
| Code | Start date | End date | Scope | Entire product | All indications | Full coverage date | Combination | Source |
|---|---|---|---|---|---|---|---|---|
| Orphan Exclusivity Exp. Date | — | 2022-11-13 | — | — | — | — | Source |
2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE
Generic approval evidence
| Application / product | Event | Final date | Tentative date | Applicant | Authorized generic | Exact mapping | Source |
|---|---|---|---|---|---|---|---|
| 761075 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2018-06-04 | — | Biocon Biologics Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761039 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2018-11-02 | — | Accord BioPharma Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761045 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2019-11-04 | — | Sandoz Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761111 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2020-06-10 | — | Hospira Inc., a Pfizer Company | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761084 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2022-05-26 | — | Kashiv BioSciences, LLC | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761173 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2022-09-01 | — | Fresenius Kabi USA, LLC | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761039 / 002 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2023-03-03 | — | Accord BioPharma Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761039 / 003 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2023-12-22 | — | Accord BioPharma Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761212 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2025-11-28 | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761147 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-05-07 | — | Accord BioPharma Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
Market Entry Information
API filings, authorized generics and linked regulatory milestones.
API Master Files & Certifications 0 records
Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.
| API | Holder / manufacturer | Holder country | Filing type | Number | Status | Filed date | Available for reference | Source | Last verified |
|---|---|---|---|---|---|---|---|---|---|
| No master-file or certification records are linked through public manufacturer portfolios. | |||||||||
Authorized Generics 0 records
Authorized generics are shown separately from independent ANDA approvals.
| Application / product | Applicant | Event / status | First marketed | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No authorized-generic records are linked to this product. | ||||||
Tentative ANDA Approvals 0 records
Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.
| Application / product | Applicant | Event / status | Tentative date | Follow-up final approval | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|---|
| No tentative-approval records are linked to this product. | |||||||
Paragraph IV Challenges 0 records
Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.
| Application / product | Applicant | Event / status | Certification event date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No structured Paragraph IV certification events are linked in the available approval evidence. | ||||||
Final ANDA Approvals 10 records
Approval dates do not establish commercial launch. Product mapping is shown for each linked record.
| Application / product | Applicant | Event / status | Final approval date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| 761075 / 001 | Biocon Biologics Inc. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2018-06-04 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761039 / 001 | Accord BioPharma Inc. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2018-11-02 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761045 / 001 | Sandoz Inc. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2019-11-04 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761111 / 001 | Hospira Inc., a Pfizer Company | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2020-06-10 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761084 / 001 | Kashiv BioSciences, LLC | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2022-05-26 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761173 / 001 | Fresenius Kabi USA, LLC | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2022-09-01 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761039 / 002 | Accord BioPharma Inc. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2023-03-03 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761039 / 003 | Accord BioPharma Inc. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2023-12-22 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761212 / 001 | Lupin Limited (Biotech Division) | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2025-11-28 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761147 / 001 | Accord BioPharma Inc. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-05-07 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
Decision evidence (1)
| Type | Date | Role | Basis | Source |
|---|---|---|---|---|
| BLA_PATENT_EXCLUSIVITY_REVIEW | — | BUSINESS_CLASSIFICATION_WITH_CONDITIONS | English description not available. | Source |
Litigation & Settlement History
Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.
No litigation or settlement record currently linked to this product.